Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01196481
Recruitment Status : Completed
First Posted : September 8, 2010
Last Update Posted : August 16, 2017
Information provided by (Responsible Party):
Institute of Liver and Biliary Sciences, India

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2015
  Study Completion Date : August 2015